Login / Signup

Sex differences in depressive symptoms and tolerability after treatment with selective serotonin reuptake inhibitor antidepressants: Secondary analyses of the GENPOD trial.

Marilia GougoulakiGlyn LewisDavid J NuttTim J PetersNicola J WilesGemma Lewis
Published in: Journal of psychopharmacology (Oxford, England) (2021)
Citalopram was not more effective in women compared with men and there was no difference in tolerability. Women and men had similar prognosis after SSRI treatment and similar prognosis regardless of antidepressant class. Findings were unaltered by menopausal status.
Keyphrases